Global qPCR Reagent Market 2017-2021
About qPCR Reagent
Quantitative Polymerase Chain Reaction (qPCR) reagent is a solution or mixture that is used in qPCR technique to amplify and quantitate Deoxyribonucleic acid (DNA) sequences in a sample. It also called as Real-time Polymerase Chain Reaction reagent. Essentially, qPCR reagents are sold in the form of separate solutions in kits or as optimized master-mixes used specifically for a function. qPCR kits called as Core kits have solutions separately in tubes with a specific quantity while master-mixes have solutions that have been measured and mixed which perform the basic functions and are available in a single tube.
Technavio’s analysts forecast the global qPCR reagent market to grow at a CAGR of 7.20% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global qPCR reagent market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global qPCR Reagent Market 2017-2021
Technavio recognizes the following companies as the key players in the global qPCR reagent market: Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, and Thermo Fisher Scientific.
Other Prominent Vendors in the market are: Cole-Parmer, Norgen Biotek, Promega, Qiagen, Sigma-Aldrich, and TAKARA BIO.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increase in M&A and internal restructuring in life science industries. Globally, R&D in the life sciences industry has the highest share among other sectors. It shares this position with information and communication technology (ICT). Most of the expenditure is focused on biopharmaceutical research although the overall industry consists of pharmaceuticals, biotechnology, medical devices, biosciences research, and testing.”
According to the report, one driver in the market is increasing demand for drug discovery and pharmacogenomics. Infectious diseases account for one-third of the overall deaths in the world. They are the second major cause of death after chronic diseases. Infectious diseases are caused by pathogens that spread directly with human contact or indirectly through air and water. These diseases also include zoonotic diseases that are spread from animals to humans. Infections caused by pathogens can lead to epidemic breakouts, and affect a mass human population.
Further, the report states that one challenge in the market is high setting-up and reagents refill costs. Although qPCR reduces the time and laborious workflow involved in DNA sequencing, the setting up and maintenance costs are high compared to other gene expression techniques such as northern blotting, DNA microarray, southern blotting. For example, cost of a 96-well plate in qPCR ranges from $150-250 while in northern blotting it is $40-$60. Also, the refill of reagents after usage is an additional cost which is difficult to manage for a firm that is just entering the industry.
Agilent Technologies, Bio-Rad Laboratories, F. Hoffmann-La Roche, and Thermo Fisher Scientific, Cole-Parmer, Norgen Biotek, Promega, Qiagen, Sigma-Aldrich, and TAKARA BIO.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook